Blue Charm blog

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients. 

The promise of Real-World Evidence/Data has always been to support clinical decision making with the highest possible quality of evidence. In practice, what does this actually mean and how does it enable us to provide better care for patients? 

Blue Charm Adherence Inc., a leading digital health technology company with a focus on creating a new standard for patient insights, engagement, and real-world evidence generation, is pleased to announce that Dean Michelin will be joining the company as an Account Director effective September 1st, 2023. Dean will play a key role within Blue Charm’s intent to accelerate its position within sample and copayment financial assistance under the brand ONE by Blue Charm™.

Introducing Blue Charm for COPD, a country-wide initiative supporting Canadians living with COPD.

Blue Charm is pleased to share the launch of our latest offering in support of people living with multiple sclerosis.

Blue Charm Adherence, a healthcare technology company, today announced that it has launched its next product offering, Blue Charm Assist.

NKS Health & Blue Charm Adherence Announce Strategic Collaboration on Digital Health Program for People Living With MS.

Blue Charm Adherence partners with the Canadian Pharmacists Association (CPhA) to help provide innovative solutions to enhance Medication Adherence for Patients with Chronic Disease.

The organization is pleased to launch its medication adherence platform within Canada in partnership with the MS Society of Canada.

Acquisition of Symbi Medical, a digital health company that provides patient engagement solutions across multiple medical specialties.

Blue Charm Adherence is pleased to announce that it has formally closed its investment offering utilizing the Nova Scotia Innovation Equity Tax Credit.

We are pleased to announce that in early March, Blue Charm Adherence became a part of the Volta incubation hub in Halifax, joining approximately another 49 technology companies.

The team at Blue Charm Adherence is very happy to report that we have closed the private offering under the Nova Scotia Innovation Equity Tax Credit program.